SOW
FATE icon

State of Wyoming’s Fate Therapeutics FATE Stock Holding History

State of Wyoming’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-94,501
Closed -$353K – 1676
2023
Q4 		$353K Buy
94,501
+80,242
+563% +$189K 0.07% 234
2023
Q3 		$30.2K Buy
+14,259
New +$47.2K 0.01% 1413
2022
Q2 		– Sell
-5,012
Closed -$194K – 1949
2022
Q1 		$194K Buy
5,012
+1,699
+51% +$65.8K 0.1% 211
2021
Q4 		$194K Buy
3,313
+657
+25% +$37.2K 0.09% 232
2021
Q3 		$157K Sell
2,656
-1,548
-37% -$121K 0.1% 244
2021
Q2 		$365K Buy
4,204
+2,613
+164% +$211K 0.23% 65
2021
Q1 		$131K Buy
+1,591
New +$152K 0.21% 84

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return